Optometrists in Tiffin, IA Accepting Medicare
2 Optometrists found. Showing 1 - 2
 Samantha Joann Harris, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 801 Buck St, Tiffin, IA 52340 Phone: 319-545-2252 |
 Axis Vision Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 801 Buck St, Tiffin, IA 52340 Phone: 319-545-2252 Fax: 319-545-2436 |
News Archive
Autistic children have a capacity to understand other people through stereotypes
The research shows that autistic children are just as able as others to predict people's behaviour when stereotypes, such as gender and race, are the only available guide.
Specific miRNAs play a key role in melanoma metastasis
Researchers at the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, identified for the first time the key role specific microRNAs play in melanoma metastasis to simultaneously cause cancer cells to invade and immunosuppress the human body's ability to fight abnormal cells.
Study links triple-negative breast cancer to ethnicity, independent of socioeconomics
An analysis of a large nationwide dataset finds that regardless of their socioeconomic status, black women were nearly twice as likely as white women to be diagnosed with triple-negative (TN) breast cancer, a subtype that has a poorer prognosis.
MicroRNAs control levels of Myc protein in Drosophila: Researchers
In all cancers, whether in kidney, breast, lung, colon, skin or any other tissue, cells show high Myc protein levels. Excess Myc causes cells to multiply in an exaggerated manner, giving rise to the development of tumours. One of the most pressing questions about Myc is how healthy cells keep the expression of this protein in check.
AIDS Healthcare Foundation criticizes Etravirine's pricing
AIDS Healthcare Foundation (AHF) has urged Tibotec Pharmaceuticals Ltd., a division of Johnson & Johnson, to reconsider and reduce its steep price for its newest AIDS drug, etravirine (TMC 125), a non-nucleoside reverse transcriptase inhibitor, (NNRTI), which received Food and Drug Administration (FDA) approval on Friday after a fast track or 'priority review' and approval process granted to companies for medications and therapies intended to treat life-threatening illnesses such as AIDS.
› Verified 7 days ago